0
0
8/16/22 at 8:50am
Organization
Healthday.com
Author
Physician’s Briefing Staff
35 words
0
Comments
No difference seen between dupilumab and placebo groups in adverse events or primary outcome of ventilator-free survival at 28 days
You are the first to view
https://consumer.healthday.com/dupilumab-aids-survival-in-patients-hospitalized-for-covid-19-2657859503.html
Create an account
or login to join the discussion